Pregabalin in Treatment of Postdural Puncture Headache
Pregabalin as Alternative to Epidural Blood Patch in Treatment of Postdural Puncture Headache: A Randomized Controlled Clinical Trial
1 other identifier
interventional
75
1 country
1
Brief Summary
Lumbar puncture (LP), often known as a "spinal tap," is a standard medical technique pioneered in the late 1900s by Heinrich Quincke. It involves the retrieval and analysis of cerebrospinal fluid (CSF) from the spinal cord, serving as the benchmark for diagnosing conditions like subarachnoid hemorrhage, meningitis, and specific neurological conditions. Pregabalin, an anticonvulsant medicine that blocks calcium entry, is used to treat a variety of diseases. It has been used to relieve pain in a variety of patient groups, including those with chronic pain, epilepsy, and anxiety disorders
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Feb 2024
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedStudy Start
First participant enrolled
February 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2024
CompletedJune 18, 2025
June 1, 2025
6 months
February 14, 2024
June 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
the incidence of complete relief
The incidence of complete relief, as reflected in the success rate of the intervention at 48 hours.
48 hours
Secondary Outcomes (1)
The intensity of the headache
48 hours
Study Arms (3)
Group A (pregabalin group)
ACTIVE COMPARATORReceived oral pregabalin treatment administered at 150 mg daily, with 75 mg given every 12 hours.
Group B (EBP group)
ACTIVE COMPARATORReceived active therapy in the form of an EBP and Group C (control group) received conservative treatment.
Group C (the control group)
ACTIVE COMPARATORreceived conservative treatment.
Interventions
Group A (pregabalin group) received oral pregabalin treatment administered at 150 mg daily, with 75 mg given every 12 hours.
Group B (EBP group) received active therapy in the form of an EBP
Group C (control group) received conservative treatment providing recommendations to the patients, including 24 hours of bed rest, stool softener, and consuming a minimum of 2.0 liters of fluid daily. Analgesics were permitted for pain relief depending on the patient's disease status.
Eligibility Criteria
You may qualify if:
- age from 21 to 65 years old,
- both genders,
- confirmed diagnosis of postdural puncture headache (PDPH)
You may not qualify if:
- patient refusal
- known allergy to the drug used in the study
- patients with a history of convulsions
- chronic headaches
- contraindications to regional anesthesia (such as local infection and coagulation abnormalities).
- Clinical indications of elevated intracranial pressure or associated risk factors
- Deteriorated patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Al-Azhar Universitylead
- Benha Universitycollaborator
Study Sites (1)
Neveen Kohaf
Tanta, 11865, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Clinical Pharmacy
Study Record Dates
First Submitted
February 14, 2024
First Posted
February 21, 2024
Study Start
February 28, 2024
Primary Completion
August 15, 2024
Study Completion
August 15, 2024
Last Updated
June 18, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
Data will be shared upon reasonable request from corresponding author